Radiology AI company with the first FDA-cleared foundation-model triage platform (CARE, January 2026); oncology-relevant for incidental findings and workflow.
CARE foundation model cleared with 11 new indications in one workflow (mean sensitivity 97%, specificity 98% in the pivotal study); Breakthrough Device designation (June 2026) for First Read, which drafts chest radiograph reports. Not oncology-specific but sets the regulatory template for imaging foundation models.
Shares No clinical claims for imaging-derived biomarkers without phantom and standards compliance, AI clears the normal lung screening scans so radiologists read only the suspicious ones, AI-assisted central imaging reads to cut endpoint cost and variability, AI that is built but not validated or deployed.
Shares Pathology & radiology foundation models, AI in oncology roadmap: pattern readers → foundation models → agents in the workflow, AI in radiology.
Shares Pathology & radiology foundation models, AI that is built but not validated or deployed, AI in radiology.
Shares Pathology & radiology foundation models, AI that is built but not validated or deployed, AI in radiology.
Shares Pathology & radiology foundation models, AI in oncology roadmap: pattern readers → foundation models → agents in the workflow, AI that is built but not validated or deployed, Not enough oncologists, nurses, pathologists, physicists.
Shares Pathology & radiology foundation models, AI in oncology roadmap: pattern readers → foundation models → agents in the workflow, AI that is built but not validated or deployed.
Shares Pathology & radiology foundation models, AI in oncology roadmap: pattern readers → foundation models → agents in the workflow, AI that is built but not validated or deployed.
Shares AI in oncology roadmap: pattern readers → foundation models → agents in the workflow, AI in radiology.
Commercial and regulated products that this organisation sells. Each card says what is behind it: a regulator's database, the literature, a public body's list, or only the company's own words. Listing is not endorsement, and a clearance is a regulatory fact, not a clinical one.
Aidoc's family of triage algorithms that push suspected findings on CT to the top of a radiologist's worklist, including incidental findings that matter in cancer care.